Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Sapienza Universita' Di Roma has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. The prosecution is currently confined to 1 distinct examiner and 1 distinct art unit, suggesting a specific focus for their active intellectual property matters. In the complex field of biotechnology, this concentration indicates that the university is currently prioritizing a specific therapeutic or diagnostic innovation. The lack of broader activity across multiple art units suggests a very targeted intellectual property strategy that relies on the successful resolution of this single pending matter.
JONES, DAMERON LEVEST is the busiest examiner, with 1 busiest examiner pending action. This single action accounts for the total 1 pending office action, meaning the university's current success in this area depends on the outcome of this specific examiner's evaluation. Practitioners must ensure that their responses are highly specific to the examiner's concerns, as there are no other active applications to provide alternative avenues for securing intellectual property protection. The university's immediate patent trajectory is thus defined by the progress of this individual application under this specific examiner.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| §112 only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PAGANO, ALEXANDER R | 1 | 78.7% | +11.4% |
| COPPINS, JANET L | 1 | 72.6% | +26.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18579426 | METHOD FOR THE EXTRACTION OF POLICOSANOLS FROM INDUSTRIAL HEMP AND MIXTURE THEREOF | PAGANO, ALEXANDER R | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18579426 | METHOD FOR THE EXTRACTION OF POLICOSANOLS FROM INDUSTRIAL HEMP AND MIXTURE THEREOF | PAGANO, ALEXANDER R | — |
| 15734695 | THIENO[2,3-B]PYRIDINE DERIVATIVES AS EPAC INHIBITORS AND THEIR PHARMACEUTICAL USES | COPPINS, JANET L | — |
| Art Unit | Apps |
|---|---|
| 1692 | 1 |
| 1628 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18579426 | METHOD FOR THE EXTRACTION OF POLICOSANOLS FROM INDUSTRIAL HEMP AND MIXTURE THEREOF | PAGANO, ALEXANDER R | 1692 | §101§102 | Non-Final OA | — | Pending | Jan 15, 2024 |
| 15734695 | THIENO[2,3-B]PYRIDINE DERIVATIVES AS EPAC INHIBITORS AND THEIR PHARMACEUTICAL USES | COPPINS, JANET L | 1628 | §112 | Non-Final OA | — | Pending | Dec 03, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSapienza Universita Di Roma has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Alexander R Pagano has the most, with 1 of Sapienza Universita Di Roma's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
